AACAP+CACAP Joint Annual Meeting
Program Schedule
Please note that this schedule is subject to change. The Program Book distributed at the Annual Meeting will have final information on dates, times, and speakers for each presentation.
Home | Search | Browse by Day or Program | Author Index


New Research Poster Presentation 4.33
A Fixed-Dose, Randomized, Double-Blind, Placebo-Controlled Study of LY2216684 in Pediatric Patients with ADHD

Friday, October 21, 2011
Daniel Lin, Ph.D., Eli Lilly and Company, Indianapolis, IN
Christopher J. Kratochvil, M.D., University of Nebraska Medical Center, Omaha, NE
Wen Xu, Ph.D., Eli Lilly and Company, Indianapolis, IN
Ling Jin, Eli Lilly and Company, Indianapolis, IN
Deborah D'Souza, i3 Statprobe, Indianapolis, IN
Albert John Allen, M.D., Ph.D., Eli Lilly and Company, Indianapolis, IN
See more of: New Research Poster Session 4
See more of: New Research Poster